A detailed history of Schonfeld Strategic Advisors LLC transactions in Absci Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 310,026 shares of ABSI stock, worth $908,376. This represents 0.01% of its overall portfolio holdings.

Number of Shares
310,026
Holding current value
$908,376
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $920,777 - $1.39 Million
310,026 New
310,026 $1.18 Million
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $62,604 - $105,380
18,359 New
18,359 $104,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $272M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.